HuGE Literature Finder
Records 1-19
|
The prevalence of homologous recombination deficiency (HRD) in various solid tumors and the role of HRD as a single biomarker to immune checkpoint inhibitors.
Journal of cancer research and clinical oncology 2021 Sep . Kim Hana, Ahn Soomin, Kim Hongsik, Hong Jung Yong, Lee Jeeyun, Park Se Hoon, Park Joon Oh, Park Young Suk, Lim Ho Yeong, Kang Won Ki, Kim Kyoung-Mee, Kim Seung T |
|
Germline Pathogenic Variants in the Ataxia Telangiectasia Mutated (ATM) Gene are Associated with High and Moderate Risks for Multiple Cancers.
Cancer prevention research (Philadelphia, Pa.) 2021 Jan . Hall Michael J, Bernhisel Ryan, Hughes Elisha, Larson Katie, Rosenthal Eric T, Singh Nanda A, Lancaster Johnathan M, Kurian Allison |
|
Differences in Genomic Alterations Between Brain Metastases and Primary Tumors.
Neurosurgery 2020 Dec . Dono Antonio, Takayasu Takeshi, Yan Yuanqing, Bundrant Bethany E, Arevalo Octavio, Lopez-Garcia Carlos A, Esquenazi Yoshua, Ballester Leomar |
|
Identification of Germline Mutations in Melanoma Patients with Early Onset, Double Primary Tumors, or Family Cancer History by NGS Analysis of 217 Genes.
Biomedicines 2020 Oct 8 (10): . Stolarova Lenka, Jelinkova Sandra, Storchova Radka, Machackova Eva, Zemankova Petra, Vocka Michal, Kodet Ondrej, Kral Jan, Cerna Marta, Volkova Zuzana, Janatova Marketa, Soukupova Jana, Stranecky Viktor, Dundr Pavel, Foretova Lenka, Macurek Libor, Kleiblova Petra, Kleibl Zden |
|
Pathogenic germline variants are associated with poor survival in stage III/IV melanoma patients.
Scientific reports 2020 Oct 10 (1): 17687. Aoude Lauren G, Bonazzi Vanessa F, Brosda Sandra, Patel Kalpana, Koufariotis Lambros T, Oey Harald, Nones Katia, Wood Scott, Pearson John V, Lonie James M, Arneil Melissa, Atkinson Victoria, Smithers B Mark, Waddell Nicola, Barbour Andrew |
|
Insights into Genetic Susceptibility to Melanoma by Gene Panel Testing: Potential Pathogenic Variants in ACD, ATM, BAP1, and POT1.
Cancers 2020 Apr 12 (4): . Pastorino Lorenza, Andreotti Virginia, Dalmasso Bruna, Vanni Irene, Ciccarese Giulia, Mandalà Mario, Spadola Giuseppe, Pizzichetta Maria Antonietta, Ponti Giovanni, Tibiletti Maria Grazia, Sala Elena, Genuardi Maurizio, Chiurazzi Pietro, Maccanti Gabriele, Manoukian Siranoush, Sestini Serena, Danesi Rita, Zampiga Valentina, Starza Roberta La, Stanganelli Ignazio, Ballestrero Alberto, Mastracci Luca, Grillo Federica, Sciallero Stefania, Cecchi Federica, Tanda Enrica Teresa, Spagnolo Francesco, Queirolo Paola, Imi Italian Melanoma Intergroup, Goldstein Alisa M, Bruno William, Ghiorzo Pao |
|
The prognostic role of BRAF and WNT pathways activation in kinase inhibitors-naïve clinical stage III cutaneous melanoma.
Melanoma research 2020 Feb . Kowalik Artur, Jurkowska Monika, Mierzejewska Ewa, Lugowska Iwona, Gos Aleksandra, Szumera-Cieckiewicz Anna, Zieba Sebastian, Kosela-Paterczyk Hanna, van der Oord Joost, Debiec-Rychter Maria, Szamotulska Katarzyna, Siedlecki Janusz, Rutkowski Pio |
|
Whole Exome Sequencing Identifies Candidate Genes Associated with Hereditary Predisposition to Uveal Melanoma.
Ophthalmology 2019 Nov . Abdel-Rahman Mohamed H, Sample Klarke M, Pilarski Robert, Walsh Tomas, Grosel Timothy, Kinnamon Daniel, Boru Getachew, Massengill James B, Schoenfield Lynn, Kelly Ben, Gordon David, Johansson Peter, DeBenedictis Meghan J, Singh Arun, Casadei Silvia, Davidorf Frederick H, White Peter, Stacey Andrew W, Scarth James, Fewings Ellie, Tischkowitz Marc, King Mary-Claire, Hayward Nicholas K, Cebulla Colleen |
|
Applicability of Routine Targeted Next-generation Sequencing to Estimate Tumor Mutational Burden (TMB) in Patients Treated With Immune Checkpoint Inhibitor Therapy.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2019 Sep . Pinato David J, Urus Heather, Newsom-Davis Thomas, Du Parcq Persephone, Belessiotis Katherine, Mapara Leah, Gupta Nandita, Power Danielle, Weir Justin, Wong Ching Ngar, Ratnakumaran Ragu P, Dominy Kathy, Khorashad Jamshid, Bower Ma |
|
Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study.
BMC cancer 2019 Aug 19 (1): 772. Casula Milena, Paliogiannis Panagiotis, Ayala Fabrizio, De Giorgi Vincenzo, Stanganelli Ignazio, Mandalà Mario, Colombino Maria, Manca Antonella, Sini Maria Cristina, Caracò Corrado, Ascierto Paolo Antonio, Satta Rosanna Rita, , Lissia Amelia, Cossu Antonio, Palmieri Giuseppe, |
|
Prognostic relevance of ATM protein in uveal melanoma and its association with clinicopathological factors.
International journal of clinical oncology 2019 Aug . Jha Jayanti, Singh Mithalesh Kumar, Singh Lata, Pushker Neelam, Bajaj Mandeep Singh, Sen Seema, Kashyap See |
|
Genetic analysis of subsequent second primary malignant neoplasms in long-term pancreatic cancer survivors suggests new potential hereditary genetic alterations.
Cancer management and research 2019 11 599-609. Lovecek Martin, Janatova Marketa, Skalicky Pavel, Zemanek Tomas, Havlik Roman, Ehrmann Jiri, Strouhal Ondrej, Zemankova Petra, Lhotova Klara, Borecka Marianna, Soukupova Jana, Svebisova Hana, Soucek Pavel, Hlavac Viktor, Kleibl Zdenek, Neoral Cestmir, Melichar Bohuslav, Mohelnikova-Duchonova Beatri |
|
Rare germline variants in known melanoma susceptibility genes in familial melanoma.
Human molecular genetics 2017 Oct . Goldstein Alisa M, Xiao Yanzi, Sampson Joshua, Zhu Bin, Rotunno Melissa, Bennett Hunter, Wen Yixuan, Jones Kristine, Vogt Aurelie, Burdette Laurie, Luo Wen, Zhu Bin, Yeager Meredith, Hicks Belynda, Han Jiali, De Vivo Immaculata, Koutros Stella, Andreotti Gabriella, Beane-Freeman Laura, Purdue Mark, Freedman Neal D, Chanock Stephen J, Tucker Margaret A, Yang Xiaohong |
|
Multiple rare variants in high-risk pancreatic cancer-related genes may increase risk for pancreatic cancer in a subset of patients with and without germline CDKN2A mutations.
Human genetics 2016 Jul . Yang Xiaohong R, Rotunno Melissa, Xiao Yanzi, Ingvar Christian, Helgadottir Hildur, Pastorino Lorenza, van Doorn Remco, Bennett Hunter, Graham Cole, Sampson Joshua N, Malasky Michael, Vogt Aurelie, Zhu Bin, Bianchi-Scarra Giovanna, Bruno William, Queirolo Paola, Fornarini Giuseppe, Hansson Johan, Tuominen Rainer, Burdett Laurie, Hicks Belynda, Hutchinson Amy, Jones Kristine, Yeager Meredith, Chanock Stephen J, Landi Maria Teresa, Höiom Veronica, Olsson Håkan, Gruis Nelleke, Ghiorzo Paola, Tucker Margaret A, Goldstein Alisa |
|
Association of Common Susceptibility Variants of Pancreatic Cancer in Higher-Risk Patients: A PACGENE Study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2016 May . Childs Erica J, Chaffee Kari G, Gallinger Steven, Syngal Sapna, Schwartz Ann G, Cote Michele L, Bondy Melissa L, Hruban Ralph H, Chanock Stephen J, Hoover Robert N, Fuchs Charles S, Rider David N, Amundadottir Laufey T, Stolzenberg-Solomon Rachael, Wolpin Brian M, Risch Harvey A, Goggins Michael G, Petersen Gloria M, Klein Alison |
|
Updated field synopsis and systematic meta-analyses of genetic association studies in cutaneous melanoma: the MelGene database.
The Journal of investigative dermatology 2015 Apr 135 (4): 1074-9. Antonopoulou Kyriaki, Stefanaki Irene, Lill Christina M, Chatzinasiou Foteini, Kypreou Katerina P, Karagianni Fani, Athanasiadis Emmanouil, Spyrou George M, Ioannidis John P A, Bertram Lars, Evangelou Evangelos, Stratigos Alexander |
|
Genetic variants in PARP1 (rs3219090) and IRF4 (rs12203592) genes associated with melanoma susceptibility in a Spanish population.
BMC cancer 2013 13 (1): 160. Peña-Chilet Maria, Blanquer-Maceiras Maite, Ibarrola-Villava Maider, Martinez-Cadenas Conrado, Martin-Gonzalez Manuel, Gomez-Fernandez Cristina, Mayor Matias, Aviles Juan Antonio, Lluch Ana, Ribas Glor |
Genome-wide association study identifies three new melanoma susceptibility loci.
Nature genetics 2011 Nov 43 (11): 1108-13. Barrett Jennifer H, Iles Mark M, Harland Mark, Taylor John C, Aitken Joanne F, Andresen Per Arne, Akslen Lars A, Armstrong Bruce K, Avril Marie-Francoise, Azizi Esther, Bakker Bert, Bergman Wilma, Bianchi-Scarrà Giovanna, Bressac-de Paillerets Brigitte, Calista Donato, Cannon-Albright Lisa A, Corda Eve, Cust Anne E, D?bniak Tadeusz, Duffy David, Dunning Alison M, Easton Douglas F, Friedman Eitan, Galan Pilar, Ghiorzo Paola, Giles Graham G, Hansson Johan, Hocevar Marko, Höiom Veronica, Hopper John L, Ingvar Christian, Janssen Bart, Jenkins Mark A, Jönsson Göran, Kefford Richard F, Landi Giorgio, Landi Maria Teresa, Lang Julie, Lubi?ski Jan, Mackie Rona, Malvehy Josep, Martin Nicholas G, Molven Anders, Montgomery Grant W, van Nieuwpoort Frans A, Novakovic Srdjan, Olsson Håkan, Pastorino Lorenza, Puig Susana, Puig-Butille Joan Anton, Randerson-Moor Juliette, Snowden Helen, Tuominen Rainer, Van Belle Patricia, van der Stoep Nienke, Whiteman David C, Zelenika Diana, Han Jiali, Fang Shenying, Lee Jeffrey E, Wei Qingyi, Lathrop G Mark, Gillanders Elizabeth M, Brown Kevin M, Goldstein Alisa M, Kanetsky Peter A, Mann Graham J, Macgregor Stuart, Elder David E, Amos Christopher I, Hayward Nicholas K, Gruis Nelleke A, Demenais Florence, Bishop Julia A Newton, Bishop D Timothy, |
|
Risk of cancer by ATM missense mutations in the general population.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008 Jun 26 (18): 3057-62. Dombernowsky Sarah Louise, Weischer Maren, Allin Kristine Højgaard, Bojesen Stig Egil, Tybjaerg-Hansen Anne, Nordestgaard Børge Grøn |
- Page last reviewed:Oct 1, 2020
- Page last updated:Sep 23, 2021
- Content source: